2309668-29-7
Chemical Structure
GSK-J1 lithium salt
- CAS. Nr.: 2309668-29-7
- Formula:C22H22LiN5O2
- Molecular Weight:395.38
IUPAC Name: lithium 3-((2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoate
InChIKey: WTBLFQHAMMUILY-UHFFFAOYSA-M
SMILES: [Li]OC(CCNC1=NC(C2=NC=CC=C2)=NC(N(CC3)CCC4=C3C=CC=C4)=C1)=O
Biological Activity: GSK-J1 lithium salt is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK-J1 lithium salt | 98.33% | GSK-J1 lithium salt is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords